Literature DB >> 35732962

Overexpression Pattern of miR-301b in Osteosarcoma and Its Relevance with Osteosarcoma Cellular Behaviors via Modulating SNX10.

Yaozong Wang1, Naikun Sun2, Zheyi Zhang3, Yuanyuan Zhou4, Hongyi Liu4, Xu Zhou5, Ying Zhang1, Yilin Zhao6.   

Abstract

Prior studies have noted the importance of microRNAs (miRNAs) in development and progression of osteosarcoma (OS), but the influence of miR-301b is less investigated. This investigation aimed to explore the biological role of miR-301b/SNX10 in OS. GSE28423 and GSE28424 arrays delivered the corresponding miR-301b and sorting nexin 10 (SNX10) expression levels in OS samples. miR-301b and SNX10 expressions were also measured by quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and western blotting in cells. Cell counting kit (CCK)-8 and transwell analysis were applied to measure cell characteristics. Luciferase reporter assay and Pearson correlation analysis were used to detect the relevance between miR-301b and SNX10. miR-301b was extremely increased in OS tissues compared with normal tissues, while SNX10 was decreased. The proliferation, invasion, and migration capabilities were limited following a low expression level of miR-301b whereas miR-301b overexpression promoted cellular malignant behaviors. miR-301b negatively targeted SNX10. The elevated SNX10 expression highlighted the inhibitory function on cell proliferation, migration, and invasion in OS cells treated by miR-301b inhibitor. Reduction of miR-301b induced the decrease of epithelial-mesenchymal transition (EMT)-related markers including N-cadherin, Vimentin, and matrix metallo-proteinase 9 (MMP)9. These results are added to the complete expanding field of the potential effects of miR-301b in OS cell malignant behaviors and demonstrate its promising role for further use to treat human OS.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Invasion; Migration; Osteosarcoma; Proliferation; SNX10; miR-301b

Year:  2022        PMID: 35732962     DOI: 10.1007/s10528-022-10241-4

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   1.890


  26 in total

Review 1.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

Review 2.  Insights into the roles of miRNAs; miR-193 as one of small molecular silencer in osteosarcoma therapy.

Authors:  Sama Izadpanah; Parastoo Shabani; Ali Aghebati-Maleki; Elham Baghbani; Amir Baghbanzadeh; Ali Fotouhi; Babak Bakhshinejad; Leili Aghebati-Maleki; Behzad Baradaran
Journal:  Biomed Pharmacother       Date:  2019-01-08       Impact factor: 6.529

3.  RECK expression in osteosarcoma: correlation with matrix metalloproteinases activation and tumor invasiveness.

Authors:  Hyun-Guy Kang; Han-Soo Kim; Kap-Jung Kim; Joo Han Oh; Mi-Ra Lee; So Mi Seol; Ilkyu Han
Journal:  J Orthop Res       Date:  2007-05       Impact factor: 3.494

4.  Downregulation of sorting nexin 10 is associated with overexpression of miR-30d during liver cancer progression in rats.

Authors:  Nancy Cervantes-Anaya; Alberto Ponciano-Gómez; Guadalupe Soledad López-Álvarez; Christian Gonzalez-Reyes; Sergio Hernández-Garcia; María Asunción Cabañas-Cortes; José Efraín Garrido-Guerrero; Saúl Villa-Treviño
Journal:  Tumour Biol       Date:  2017-04

5.  Controversies in childhood osteosarcoma.

Authors:  S Bielack; B Kempf-Bielack; T Von Kalle; R Schwarz; T Wirth; L Kager; J Whelan
Journal:  Minerva Pediatr       Date:  2013-04       Impact factor: 1.312

6.  MicroRNA-130a promotes the metastasis and epithelial-mesenchymal transition of osteosarcoma by targeting PTEN.

Authors:  Jiansong Chen; Dingding Yan; Weiliang Wu; Jian Zhu; Wensong Ye; Qiang Shu
Journal:  Oncol Rep       Date:  2016-03-31       Impact factor: 3.906

Review 7.  Epithelial-mesenchymal transition (EMT) and metastasis: yes, no, maybe?

Authors:  Maren Diepenbruck; Gerhard Christofori
Journal:  Curr Opin Cell Biol       Date:  2016-06-29       Impact factor: 8.382

Review 8.  Osteopontin as a biomarker for osteosarcoma therapy and prognosis.

Authors:  Xingwen Han; Wenji Wang; Jingjing He; Lei Jiang; Xun Li
Journal:  Oncol Lett       Date:  2019-01-08       Impact factor: 2.967

9.  microRNA-194 suppresses osteosarcoma cell proliferation and metastasis in vitro and in vivo by targeting CDH2 and IGF1R.

Authors:  Kang Han; Tingbao Zhao; Xiang Chen; Na Bian; Tongtao Yang; Qiong Ma; Chengkui Cai; Qingyu Fan; Yong Zhou; Baoan Ma
Journal:  Int J Oncol       Date:  2014-07-30       Impact factor: 5.650

10.  The miR-130 family promotes cell migration and invasion in bladder cancer through FAK and Akt phosphorylation by regulating PTEN.

Authors:  Hiroshi Egawa; Kentaro Jingushi; Takayuki Hirono; Yuko Ueda; Kaori Kitae; Wataru Nakata; Kazutoshi Fujita; Motohide Uemura; Norio Nonomura; Kazutake Tsujikawa
Journal:  Sci Rep       Date:  2016-02-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.